This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| National HIV Surveillance System | |
|---|---|
| Name | National HIV Surveillance System |
| Formation | 1982 |
| Type | Public health surveillance |
| Headquarters | Atlanta, Georgia |
| Location | United States |
| Leader title | Director |
| Parent organization | Centers for Disease Control and Prevention |
National HIV Surveillance System
The National HIV Surveillance System monitors human immunodeficiency virus incidence and prevalence across the United States and its territories. It provides epidemiologic data used by agencies such as the Centers for Disease Control and Prevention, Health Resources and Services Administration, Substance Abuse and Mental Health Services Administration, and state health departments including the New York State Department of Health and the California Department of Public Health. The system informs programs funded by the Ryan White HIV/AIDS Program, shapes guidance from the Advisory Committee on Immunization Practices, and supports research by institutions like the Johns Hopkins Bloomberg School of Public Health and the Harvard T.H. Chan School of Public Health.
The surveillance system aggregates case reports of HIV infection from jurisdictions including Puerto Rico Department of Health, District of Columbia Department of Health, Centers for Medicare & Medicaid Services-linked datasets, and laboratory reporting networks such as laboratories affiliated with Quest Diagnostics and LabCorp. It interfaces with electronic health records from hospitals like the Mayo Clinic and academic medical centers such as Massachusetts General Hospital and Brigham and Women's Hospital. Data elements support analyses by research centers including the Kaiser Family Foundation, the Guttmacher Institute, and the Urban Institute. Surveillance outputs inform policy discussions in forums like the Institute of Medicine and the National Academies of Sciences, Engineering, and Medicine.
Surveillance traces to early reports of opportunistic infections in the 1980s documented in journals like the Morbidity and Mortality Weekly Report and research from investigators at the Centers for Disease Control and Prevention and the National Institutes of Health. Early partners included the World Health Organization, Pan American Health Organization, and academic investigators at Columbia University and University of California, San Francisco. Legislative influences included statutes debated in the United States Congress and initiatives under the Public Health Service Act. Surveillance methods evolved alongside diagnostics developed by companies such as Abbott Laboratories and research at the Fred Hutchinson Cancer Research Center. Collaborations involved community organizations like the Gay Men's Health Crisis and the National Association of People with AIDS.
Governance is centered at the Centers for Disease Control and Prevention with advisory input from panels like the Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment and coordination with the Association of State and Territorial Health Officials and the National Association of County and City Health Officials. Jurisdictional reporting is managed by state health departments including the Texas Department of State Health Services and the Florida Department of Health. Legal counsel engages with the Department of Justice and the Office for Civil Rights for privacy compliance. Funding streams pass through agencies such as the Health Resources and Services Administration and programmatic oversight involves the Substance Abuse and Mental Health Services Administration and the Department of Health and Human Services.
Data sources include case reporting by clinicians at institutions like Johns Hopkins Hospital and laboratories affiliated with Bio-Rad Laboratories, automated laboratory reporting from networks such as Laboratory Corporation of America, and electronic reporting via health information exchanges including CommonWell Health Alliance. Surveillance integrates data from the Ryan White HIV/AIDS Program, claims data from Centers for Medicare & Medicaid Services, and mortality data from the National Center for Health Statistics. Methodologies employ statistical tools developed by research groups at University of California, Los Angeles, Emory University, and University of North Carolina at Chapel Hill and use standards from organizations like Health Level Seven International and the National Institute of Standards and Technology.
Surveillance data guide allocation of resources to programs funded under the Ryan White HIV/AIDS Program, inform prevention strategies by the Centers for Disease Control and Prevention and clinical guidelines by organizations such as the Infectious Diseases Society of America and the American Academy of Pediatrics. Data underpin modeling studies at the Brookings Institution and the RAND Corporation and support clinical trials coordinated by networks like the HIV Vaccine Trials Network and the International AIDS Vaccine Initiative. Surveillance findings influence policymaking in the United States Senate and public health planning at municipal levels such as in San Francisco Department of Public Health and Chicago Department of Public Health.
Protections draw on statutes and regulations including the Health Insurance Portability and Accountability Act of 1996 and guidance from the Office for Civil Rights (United States Department of Health and Human Services). State statutes vary; legal frameworks are interpreted by offices such as the New York State Office of the Attorney General and litigated in federal courts including the United States Court of Appeals for the Ninth Circuit. Ethical oversight involves institutional review boards at institutions like Yale School of Medicine and the University of Pennsylvania Perelman School of Medicine. Data-sharing agreements reference standards promulgated by Centers for Medicare & Medicaid Services and the National Institutes of Health.
Challenges include underreporting in marginalized communities served by organizations like Southern AIDS Coalition and disparities documented by analyses from the Kaiser Family Foundation and the Henry J. Kaiser Family Foundation. Technological advances in genomic epidemiology from the Broad Institute and machine learning from researchers at Carnegie Mellon University offer future enhancements. Integration with global initiatives such as the Joint United Nations Programme on HIV/AIDS and collaborations with entities like Médecins Sans Frontières could inform best practices. Ongoing work involves improvement of interoperability standards from Health Level Seven International, enhanced privacy frameworks advised by the Electronic Frontier Foundation, and funding decisions by the United States Department of Health and Human Services and the Office of Management and Budget.
Category:Public health surveillance in the United States